PubMed (Bookshelf cited) for id: 140272

Year	Number of Results
1976	1
1992	1
1996	1
1997	1
1998	1
2000	4
2001	1
2002	2
2003	3
2004	1
2005	4
2006	1
2007	2
2008	4
2009	1
2010	4
2011	2
2012	1
2013	2
2014	2
2015	7
2016	1
2017	2
2018	4
2019	3
2020	2
2021	1
2022	5
2023	2
2024	0

1

Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.

Kowdley KV, Modi NB, Peltekian K, Vierling JM, Ferris C, Valone FH, Gupta S. Kowdley KV, et al. Lancet Gastroenterol Hepatol. 2023 Dec;8(12):1118-1128. doi: 10.1016/S2468-1253(23)00250-9. Epub 2023 Oct 17. Lancet Gastroenterol Hepatol. 2023. PMID: 37863080 Clinical Trial.

2

Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y.

Barton JC, Barton JC, Acton RT. Barton JC, et al. BMC Gastroenterol. 2023 Apr 28;23(1):137. doi: 10.1186/s12876-023-02763-x. BMC Gastroenterol. 2023. PMID: 37118679 Free PMC article.

3

Hemochromatosis.

Olynyk JK, Ramm GA. Olynyk JK, et al. N Engl J Med. 2022 Dec 8;387(23):2159-2170. doi: 10.1056/NEJMra2119758. N Engl J Med. 2022. PMID: 36477033 Review. No abstract available.

4

Twenty-Five Years of Contemplating Genotype-Based Hereditary Hemochromatosis Population Screening.

Schmidtke J. Schmidtke J. Genes (Basel). 2022 Sep 9;13(9):1622. doi: 10.3390/genes13091622. Genes (Basel). 2022. PMID: 36140790 Free PMC article. Review.

5

Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p.C282Y/p.C282Y.

Barton JC, Barton JC, Acton RT. Barton JC, et al. PLoS One. 2022 Jul 27;17(7):e0271973. doi: 10.1371/journal.pone.0271973. eCollection 2022. PLoS One. 2022. PMID: 35895739 Free PMC article.

6

EASL Clinical Practice Guidelines on haemochromatosis.

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, et al. J Hepatol. 2022 Aug;77(2):479-502. doi: 10.1016/j.jhep.2022.03.033. Epub 2022 Jun 1. J Hepatol. 2022. PMID: 35662478

7

USPSTF Approach to Addressing Sex and Gender When Making Recommendations for Clinical Preventive Services.

Caughey AB, Krist AH, Wolff TA, Barry MJ, Henderson JT, Owens DK, Davidson KW, Simon MA, Mangione CM. Caughey AB, et al. JAMA. 2021 Nov 16;326(19):1953-1961. doi: 10.1001/jama.2021.15731. JAMA. 2021. PMID: 34694343

8

Hemochromatosis classification: update and recommendations by the BIOIRON Society.

Girelli D, Busti F, Brissot P, Cabantchik I, Muckenthaler MU, Porto G. Girelli D, et al. Blood. 2022 May 19;139(20):3018-3029. doi: 10.1182/blood.2021011338. Blood. 2022. PMID: 34601591 Free PMC article.

9

Long-term Outcome of Orthotopic Liver Transplantation in Patients With Hemochromatosis: A Summary of a 30-year Transplant Program.

Dobrindt EM, Keshi E, Neulichedl J, Schöning W, Öllinger R, Pratschke J, Eurich D. Dobrindt EM, et al. Transplant Direct. 2020 May 28;6(6):e560. doi: 10.1097/TXD.0000000000001007. eCollection 2020 Jun. Transplant Direct. 2020. PMID: 33062844 Free PMC article.

10

Systematic Review of the Clinical Outcomes of Iron Reduction in Hereditary Hemochromatosis.

Prabhu A, Cargill T, Roberts N, Ryan JD. Prabhu A, et al. Hepatology. 2020 Oct;72(4):1469-1482. doi: 10.1002/hep.31405. Hepatology. 2020. PMID: 32500577 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

59 results

Results by year